Search
Search Results

No Search Results Found

LIVE
Search
Search Results

No Search Results Found

Explore HomeNewsPodcastsBreaking NewsSocial Watch Live Infowars NetworkThe Alex Jones ShowThe War Room with Owen ShroyerThe American Journal More Banned.VideoInfowars StoreArchiveRSSDownload Our App

Terms of Service

DMCA

Advertise with us

Affiliates

Media Inquiries

About

Editors Choice

Pfizer CEO Declares Alex Jones Enemy #1 – Learn Why

The Alex Jones Show | Infowars.com
November 22nd 2022, 12:39 pm
Watch & share this link to learn how globalists wield their monopoly over any narrative by accusing opposition of what they themselves are doing!
Image Credit:
Steven Ferdman / Contributor / Getty
Share

Dr. Albert Bourla, the Chairman and CEO of pharma giant Pfizer, received a “Courage Against Hate” award from the Anti-Defamation League (ADL) earlier this month where he made a speech condemning Infowars founder Alex Jones.

Watch & share this explosive video report where Alex Jones gives a crash course on how globalists wield their monopoly over any narrative!

RELATED: Pfizer CEO Bourla Applauds Alex Jones Sandy Hook Verdicts, Calls Him An ‘Agent Of Evil’



Don’t miss:

Andrew Tate Talks About The Power Of Young Men

Left-wing radicals are attempting to destroy Alex Jones via the court system! Please help Alex by making a donation to his legal defense at Saveinfowars.com to keep him in the fight! Don't let the NWO be successful with their latest weapon against Free Speech!
Share
LIVE

In case you missed it...
Editors Choice

Editors Choice

Flashback: Kanye Warned About ‘Protecting Kids’ From Subliminal Messages in Media

posted 2 days ago

Editors Choice

Swiss Captain Rejects World Cup Virtue Signaling

posted 2 days ago

Editors Choice

Photographer Hired For Balenciaga ‘Kiddie BDSM’ Shoot Says He’s Being Made a Scapegoat

posted 3 days ago

Editors Choice

Balenciaga Apologizes For Vile Kiddie Bondage Ad Featuring Child Porn Prop

posted 4 days ago

View More From Editors Choice
Terms of ServiceDMCAAdvertise with usAffiliatesMedia InquiriesAbout